Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 23, 2013

View Archived Issues

The discovery and characterization of a first-in-class agent against tuberculosis

Novel lung cancer vaccine CV-9202 evaluated in phase I trial

Phase I study of AG-221 commences in advanced hematological malignancies

The identification of novel genetic mutations in children with epilepsy

New aminoglycoside antibiotic for Gram-negative infections

BTK inhibitors described by Beta Pharma

New antiarrythmics reported by Sanofi

Pfizer discloses novel sodium channel blockers for pain

Successful generation of clinical-grade iPSCs from research-grade cells

The discovery and validation of a topical solution to improve allogeneic corneal graft survival

Sera Prognostics' PAPR study of PreTRM preterm birth test reaches full enrollment

UK DFID supports Drugs for Neglected Diseases initiative

HypoThermosol used in two Intercytex trials of cell-based wound care

Preclinical toxicology study of intravenous PG-545 completed

FDA accepts Pennsaid 2% NDA for review

Sobi seeks European approval for Orfadin oral suspension

Plethora and Shionogi expand agreement for PSD-502

Chugai Pharmaceutical seeks additional formulation approval for Cellcept

Galapagos divulges new series of tyrosine-protein kinase inhibitors

Astellas launches Astagraf XL in U.S. for prophylaxis of organ rejection after kidney transplant

Boehringer Ingelheim to launch Gilotrif tablets in the U.S. in early September

Shire and Santaris extend partnership to develop drugs for rare genetic diseases

C3 Jian completes phase I trial of therapeutic for prevention of tooth decay

EnteraGam launched for the dietary management of IBS-D

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...